Osaic Holdings’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Osaic Holdings’s Portfolio LDRS Stock Details LDRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,400	Closed	-$67K	–	7526
2021 Q2	$67K	Hold	2,400	–	–	﹤0.01%	4816
2021 Q1	$64K	Hold	2,400	–	–	﹤0.01%	4702
2020 Q4	$69K	Hold	2,400	–	–	﹤0.01%	4328
2020 Q3	$58K	Sell	2,400 -500	-17%	-$11.6K	﹤0.01%	4202
2020 Q2	$59K	Sell	2,900 -1,017	-26%	-$19.4K	﹤0.01%	4081
2020 Q1	$73K	Buy	+3,917	New	+$83.8K	﹤0.01%	3710

Osaic Holdings's LDRS Position: Q3 2021 in Review

Osaic Holdings sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q3 2021, closing a stake of 2,400 shares — an estimated $67K sold.

Osaic Holdings first reported a position in LDRS in Q1 2020 and held it in 6 quarters. The position peaked at $73K in Q1 2020. 0 funds tracked by Wall St. Rank hold LDRS as of Q3 2021.

Osaic Holdings reported no remaining Innovator IBD ETF Leaders ETF position as of Q3 2021 after selling out during the quarter.
Osaic Holdings sold 2,400 Innovator IBD ETF Leaders ETF shares in Q3 2021, an estimated $67K.
Osaic Holdings first reported a position in Innovator IBD ETF Leaders ETF in Q1 2020 and held it in 6 quarters.
Osaic Holdings's Innovator IBD ETF Leaders ETF position peaked at $73K in Q1 2020.
0 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q3 2021.

Based on Osaic Holdings's 13F filing for Q3 2021, filed 5 Nov 2021.